The tweet was deleted by the author.
But we saved everything 🙂.
Quantum-Si is set to host a new webcast in collaboration with Nature Custom on December 10th. The event will feature Nigel O'Neil, PhD of Arrowsmith Genetics, who will delve into the use of next-generation protein sequencing in precision oncology drug development.
This webcast highlights the ongoing advancements in biotechnological innovations and aims to provide insights into how these developments can revolutionize cancer treatment and drug development processes. Participants are encouraged to register for what promises to be an insightful discussion on cutting-edge research and its applications in medicine.
These upcoming discussions on precision oncology not only underscore the scientific momentum in protein sequencing but also reflect broader strategic themes recently observed when Quantum-Si unveiled its Q3 2025 earnings results. Such events, reminiscent of the anticipation seen around the company's investor day, continue to shape investor expectations and signal the direction of future innovations in proteomics.